Indian Immunologicals gets DCGI nod for Measles-Rubella vaccine

Summary by Ground News

Vaccine maker Indian Immunologicals (IIL) has received approval from the Drugs Controller General of India (DGCI) and Telangana State Drug Control Administration (DCA) for manufacturing Measles-Rubella (MR) vaccine. IIL is collaborating with Vietnam's Center for Research and Production of Vaccines and Biologicals, also known as Polyvac.

Published 2 months ago · Viet Nam

News Articles

More Filters

All

Left

Center

Right

The Hindu

Indian Immunologicals gets DCGI nod for Measles-Rubella vaccine

Vietnam’s Center for Research and Production of Vaccines and Biologicals, also known as Polyvac, will be supplying the measles vaccine component, while the rubella vaccine component will be produced by IIL to manufacture a combined MR vaccine.

2 months ago·India

Read Full Article